Citadel Advisors’s Niagen Bioscience NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.34M Buy
530,477
+138,937
+35% +$750K ﹤0.01% 5756
2025
Q4
$2.49M Buy
391,540
+192,237
+96% +$1.34M ﹤0.01% 5513
2025
Q3
$1.86M Buy
+199,303
New +$2.01M ﹤0.01% 6224
2025
Q2
Sell
-106,899
Closed -$1.06M 16013
2025
Q1
$738K Buy
106,899
+80,284
+302% +$504K ﹤0.01% 7625
2024
Q4
$141K Buy
26,615
+26,313
+8,713% +$144K ﹤0.01% 10983
2024
Q3
$1.1K Sell
302
-9,650
-97% -$30.4K ﹤0.01% 13900
2024
Q2
$27.2K Sell
9,952
-31,081
-76% -$104K ﹤0.01% 12363
2024
Q1
$143K Sell
41,033
-138,662
-77% -$257K ﹤0.01% 10832
2023
Q4
$257K Buy
179,695
+6,925
+4% +$9.65K ﹤0.01% 9472
2023
Q3
$252K Sell
172,770
-14,443
-8% -$22.6K ﹤0.01% 9486
2023
Q2
$294K Sell
187,213
-22,779
-11% -$34K ﹤0.01% 9095
2023
Q1
$321K Buy
209,992
+59,701
+40% +$106K ﹤0.01% 9238
2022
Q4
$252K Buy
150,291
+93,726
+166% +$149K ﹤0.01% 9679
2022
Q3
$70K Sell
56,565
-316,992
-85% -$510K ﹤0.01% 11393
2022
Q2
$623K Buy
373,557
+264,478
+242% +$517K ﹤0.01% 8159
2022
Q1
$268K Sell
109,079
-38,144
-26% -$104K ﹤0.01% 10844
2021
Q4
$551K Buy
147,223
+112,257
+321% +$606K ﹤0.01% 9459
2021
Q3
$219K Buy
34,966
+5,740
+20% +$47.3K ﹤0.01% 11804
2021
Q2
$288K Sell
29,226
-44,081
-60% -$384K ﹤0.01% 11372
2021
Q1
$685K Buy
+73,307
New +$581K ﹤0.01% 8992
2020
Q3
Sell
-29,704
Closed -$137K 11015
2020
Q2
$137K Sell
29,704
-43,751
-60% -$196K ﹤0.01% 8803
2020
Q1
$239K Buy
+73,455
New +$282K ﹤0.01% 7711
2019
Q1
Sell
-21,050
Closed -$72K 10081
2018
Q4
$72K Sell
21,050
-23,286
-53% -$80.9K ﹤0.01% 8385
2018
Q3
$190K Buy
44,336
+27,315
+160% +$117K ﹤0.01% 8247
2018
Q2
$63K Sell
17,021
-42,319
-71% -$161K ﹤0.01% 8392
2018
Q1
$249K Buy
+59,340
New +$311K ﹤0.01% 7018

Other funds holding NAGE